To buy shares in Allogene Therapeutics Inc. you will need a US based stock trading platform like Interactive Brokers or Moomoo where it currently costs $2.05 to buy one share in Allogene Therapeutics Inc. (as of 16:00 14-Aug-2026). Which is a change of $0.07 or 3.54% from the last closing price of $1.98.
How To Buy Allogene Therapeutics Inc. Stock
It may seem complicated to buy stock for the first time, but it’s actually very easy. Follow these simple steps to buy shares in Allogene Therapeutics Inc.:
- Pick a stock broker (jump down to compare the best brokers for buying Allogene Therapeutics Inc. stock)
- Deposit funds (bank transfer, ACH, wire transfer, or card)
- Search for the stock symbol: (NASDAQ:ALLO)
- Choose the number of shares you want to buy (1 share currently costs $2.05)
- Click buy (you can either trade immediately at “market” or set a “limit” to buy the stock cheaper if you think the price will go down)
- Track the performance of your Allogene Therapeutics Inc. stock in your account (this will show your profit and loss)
[qmod detailedquotetabchart ALLO:US name=”Allogene Therapeutics Inc.” show_profile=”1″ ticker=”ALLO” heading=”h2″]
- Allogene Therapeutics Inc. is currently worth $708,256,328 based on the last closing price of $1.98 with 4,605,119 shares traded.
- The most recent Allogene Therapeutics Inc. daily high has been $2.08 and daily low $1.92.
- The Allogene Therapeutics Inc. stock price 52 week high has been $4.46 and the 52 week low $1.03.
Compare Brokers For Buying Allogene Therapeutics Inc. Stock
It’s usually commission-free to buy US stocks as American stock brokers make their money from payment for order flow. However, there can sometimes be additional charges for buying stocks in an IRA, where your contributions are tax-deductible.
| Name | Logo | GMG Rating | Customer Reviews | Stocks Available | Stock Trading Costs | CTA | Feature | Expand |
|---|---|---|---|---|---|---|---|---|
 | GMG Rating | Customer Reviews | Stocks Available 17,913 | Stock Trading Costs 0.003% | Features:
| Interactive Brokers stock trading makes them one of the best US stock brokersAccount: Interactive Brokers Stock Trading Description: Amazing technology, and always first to market with innovative trading tools. Interactive Brokers lets you trade stock on 90+ international exchanges, with $0 commission and some of the lowest financing rates in the industry. Is Interactive Brokers a good stock broker? Yes, IBKR is an excellent US stock broker, low costs, excellent market access and superb apps and platforms. Pricing: Interactive Brokers is very cheap for trading stocks, especially in the IBKR Lite account, where commissions are $0 on US-listed stocks and fractional stocks. For more advanced traders, IBKR Pro commissions are USD 0.0005 to USD 0.0035 per share, but you get significant price improvements from IB SmartRouting. If you are trading stocks on margin, Interactive Brokers have some of the lowest margin loan financing rates in the industry from USD 4.83% to USD 5.83%. You can also actually get IBKR to pay you by letting them borrow your fully paid up stocks and letting them lend them out to short sellers, through their stock yield enhancement program. Market Access: IBKR probably has the best market access of all the stock brokers we compare. You can trade a huge range of international stocks and IBKR has local access to over 90 stock exchanges. There are very few stocks you cannot trade on IBKR. Apps & Platforms: Interactive Brokers’ stock trading apps and platforms are seriously good. When I traded on the desktop workstation platform, I was able to pair trade two stocks against each other. IBKR is one of the few platforms that allows you to do this. Probably because when I interviewed IBKR founder Thomas Peterffy before testing the platforms, he told me that he thinks the most successful stock traders are ones that trade one company against another. Customer Service: Because Interactive Brokers is one of the largest stock brokers in the world, customer service is largely automated and they were even using automated chatbots before the AI revolution took over. This is a good example of how they are at the forefront of stock trading technology. However, it can be a bit of a pain trying to get through to someone on the phone if you are not a large customer with a personal stock broker. Research & Analysis: You get lots of research and analysis from Interactive Brokers, including the IBKR Campus, for beginners to improve their stock trading. For longer-term investors, there is fundamental data on 30,000 companies and over 5,000 analyst ratings to give you an indication of whether a stock is a buy or a sell.
Pros
Cons
Overall4.8 | ||
 | GMG Rating | Customer Reviews | Stocks Available 5,000+ | Stock Trading Costs $0 | Features:
| Moomoo’s US platform offers commission-free trading on US stocks, ETFs, and OTC shares, with access to international stocks and ADRs from a single account. The platform includes free real-time quotes, Level 2 market data, advanced charting with 60+ technical indicators, and stock screening tools to help investors analyse markets. Traders can use mobile and desktop apps with integrated research, news, paper trading, and TradingView connectivity, aimed primarily at active and self-directed investors. Moomoo Review: A nod to bullish trading and investingProvider: Moomoo Verdict: Moomoo is an online trading and investing platform developed by Futu Holdings, a technology-driven brokerage firm based in Hong Kong. Moomoo offers a range of long term investment products like fractional stocks and ETFs as well as speculative options and margin trading. Is Moomoo any good? Moomoo is available in Canada, Australian Singapore and the US and has a robust platform that caters to both retail and more sophisticated traders. Compared to platforms like Robinhood and Webull it’s got better data, DMA and global market access. However, for active traders it’s not as institutional grade as Interactive Brokers or more established platforms like TD Ameritrade’s thinkorswim. There are a few key features to Moomoo like real-time market data and advanced charting where you can trade DMA, with good technical indicators for advanced traders. There is also a good demo trading account so you can practice before you deposit real funds. You can also make a automatic buy sell order on Moomoo with OCO stop and limit orders for effective risk management of positions. We consider Moomoo a safe trading platform as they are regulated by the SEC in the US, the MAS in Singapore and ASIC in Australia. Pros
Cons
Overall4.5 |
Is Now A Good Time To Buy Allogene Therapeutics Inc. Stock?
- Allogene Therapeutics Inc.’s EPS (earnings per share) are 0.67. A high EPS indicates strong profitability but may already be priced in, while a low EPS could signal weak earnings or a turnaround opportunity, requiring industry comparison.
- Allogene Therapeutics Inc.’s PE (price earnings ratio) is n/a. A low PE ratio may suggest undervaluation but could also indicate slow growth or risk, whereas a high PE ratio reflects high growth expectations but may signal overvaluation, necessitating a check on earnings sustainability.
The below Allogene Therapeutics Inc. share price analysis and market data includes key financials, earnings estimates, peer performance, dividends, news and a company profile that will give you an indication as to whether this stock is a buy, sell or hold. Subscribe to Good Money Guide Analysis for expert opinion on the latest investment opportunities.
[qmod analyst|earnings|financials|financialsummary|pricehistory|interactivechart|dividends|corporateevents|shareinfoperformance|fullnews|companyprofile ALLO:US name=”Allogene Therapeutics Inc.” show_profile=”1″ ticker=”ALLO” heading=”h2″]